title: Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
abstract: Estrogens (estrone [E1] and estradiol [E2]), their sulfates and progesterone receptor (PR) were evaluated in patients with uterine leiomyomata nontreated and treated with Decapeptyl (D-Trp6-gonadotropin-releasing hormone [GnRH]; Ipsen Biotech, Paris, France). Estrogen concentrations are very high in the leiomyoma (secretory phase, pg/g tissue [mean +/- SEM]: n = 10; E1: 147 +/- 24; E2: 850 +/- 116; E1-sulfate: 1,668 +/- 808; E2-sulfate: 718 +/- 126). Decapeptyl treatment provokes a significant decrease in E2 and particularly in E1 and E2 sulfates. Progesterone receptors were higher in the leiomyoma than in the myometrium; after a long treatment (3 to 4 months) a significant decrease in both tissues is observed. The decrease provoked by D-Trp6-GnRH on estrogens (unconjugated and sulfates) and in PR in the leiomyoma after long treatment, supports the hypothesis that estrogens are implicated in the cause of these tumors.
authors: C.N.R.S. Steroid Hormone Research Unit, Foundation for Hormone Research, Paris, France.
authors: J R
authors: JR
authors: Pasqualini
authors: E
authors: E
authors: Cornier
authors: J
authors: J
authors: Grenier
authors: C
authors: C
authors: Vella
authors: B
authors: B
authors: Schatz
authors: A
authors: A
authors: Netter
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004958:Estradiol / Q000031:analogs & derivatives / Q000378:metabolism; D004967:Estrogens / Q000378:metabolism*; D004970:Estrone / Q000031:analogs & derivatives / Q000378:metabolism; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy*; D008875:Middle Aged; D009215:Myometrium / Q000187:drug effects* / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism*; D017329:Triptorelin Pamoate; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D004967:Estrogens; D011980:Receptors, Progesterone; D017329:Triptorelin Pamoate; C031555:estradiol sulfate; D004970:Estrone; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; C017296:estrone sulfate